Is There an Advantage to Venlafaxine in Comparison with Other Antidepressants?
- 1 January 1997
- journal article
- Published by Wiley in Human Psychopharmacology: Clinical and Experimental
Abstract
No abstract availableKeywords
This publication has 52 references indexed in Scilit:
- Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysisBMJ, 1995
- A double-blind comparison of venlafaxine and fluoxetine in patients hospitalized for major depression and melancholiaInternational Clinical Psychopharmacology, 1994
- Binding of antidepressants to human brain receptors: focus on newer generation compoundsPsychopharmacology, 1994
- Blockade by newly-developed antidepressants of biogenic amine uptake into rat brain synaptosomesLife Sciences, 1993
- Fluoxetine Compared with Imipramine in the Treatment of Inpatient Depression A Multicenter TrialAnnals of Clinical Psychiatry, 1993
- The effect of selective serotonin re‐uptake inhibitors on cytochrome P4502D6 (CYP2D6) activity in human liver microsomes.British Journal of Clinical Pharmacology, 1992
- Quantification and mechanism of the fluoxetine and tricyclic antidepressant interactionClinical Pharmacology & Therapeutics, 1992
- High-Dose FluoxetineJournal of Clinical Psychopharmacology, 1991
- Rapid down regulation of β-adrenoceptors by co-administration of desipramine and fluoxetineEuropean Journal of Pharmacology, 1988
- The Evidence for 20 mg a day of Fluoxetine as the Optimal Dose in the Treatment of DepressionThe British Journal of Psychiatry, 1988